Abstract
The aminoglycosidic antibiotic, neomycin B, is an inhibitor of the binding of Rev to RRE. This paper reports on the synthesis of analogs of neomycin B as potential anti-HIV compounds designed to function as inhibitors of Rev/RRE binding.
We're pleased that you plan to submit your article! Before starting your submission, please check that this journal's publishing policy is compatible with your and your co-authors' funding agreements. Taylor & Francis requires you to delay making an Accepted Manuscript version of your article available if you are not publishing Open Access.
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.